Fintel on MSN1d
Leerink Partners Initiates Coverage of ICON Public Limited (ICLR) with Outperform Recommendation
Fintel reports that on September 18, 2024, Leerink Partners initiated coverage of ICON Public Limited (NasdaqGS:ICLR) with a ...
The best free software that's completely safe (we've checked)
Discover how to save money with brilliant free office software, photos editors and more – plus how to stay safe when ...
ICON draws bullish view at Leerink on business model
ICON Public Limited (ICLR) stock gained as Leerink launched its coverage with a bullish view, citing its business focused on ...
Business Insider1d
Buy Rating Affirmed for Rocket Pharmaceuticals Amid Clinical Progress and Robust Phase 2 Trial Prospects
are key drivers of Ijem’s optimistic outlook for the company’s stock. Furthermore, beyond the immediate trial, there is a broader potential for approval and product launches from Rocket’s lentiviral ...
Daily Maverick on MSN2d
SA Company Results: The Latest
Your one-stop shop for all the latest corporate results of South Africa’s major companies. South African lender FirstRand ...
Business Insider2d
Buy Rating for Rocket Pharmaceuticals Amid Positive Projections for RP-A501 Danon Disease Study
The FDA’s indication that long-term benefits in secondary measures could forgo the need for a separate confirmatory study further bolsters the positive outlook. These aspects ... approach applies the ...